Mechanistically, B6H12 treatment facilitates the expression of exosomal microRNA-7 in breast cancer stem cells, which targets EGFR and KLF4 mRNAs, leading to decreased EGFR, KLF4, and EGF-induced EGFR tyrosine phosphorylation [183]. The gene discussed is EGFR; the disease is breast cancer.